secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001140361-23-005030
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Roivant Sciences prices upsized public offering of 30.7M common shares at $7.50, raising ~$230M gross
--------------------------------------------------------------------------------

- Offering of 30,666,665 shares priced at $7.50 per share; gross proceeds ~$230M before expenses.
- Upsized from initial 26,666,666 shares; underwriters' 30-day option exercised in full.
- Bookrunners: Goldman Sachs, SVB Securities, Cowen, Cantor Fitzgerald.
- Shares sold by Roivant; offering closed February 7, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000114036123005030/0001140361-23-005030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000114036123005030/ny20006513x5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-005030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer